Xiaoming H.
Regulatory & Scientific Consultant
Regulatory affairs consultant with 10+ years in US and Canadian consumer health — dietary supplements, NHPs, OTC drugs, and nutritionals. I help brands get products to market and keep them compliant, from label, claim review, to ads and promotional materials. What I can take off your plate: • Label & claim review — US Nutiion/Supplement/Drug Facts panels, Health Canada NHP labels, artwork and advertising copy, reviewed against FDA, FTC, and NHPR requirements with written findings and recommended edits • Claim substantiation — literature reviews and evidence summaries you can hand to Legal, a regulator, or a retailer without further rewriting • Ingredient & formula review — permissibility, identity, conditions of use, and safety documentation • Health Canada NHP support — product classification, dossier preparation, and submission support • China market & cross-border e-commerce — regulatory requirements for nutritionals and supplements sold into China through CBEC; bilingual review of Chinese labeling, claims, and marketing content • Regulatory intelligence — monitoring FDA warning letters, FTC actions, and state-level developments, summarized into short action items rather than a news digest • Regulatory & scientific writing — substantiation reports, regulatory memos, dossiers Why clients work with me: I deliver written, defensible recommendations instead of hedged opinions. I confirm scope and deadline before starting, and I tell you upfront if something needs a different specialist rather than guessing. Background: M.S. Nutrition Sciences. Former regulatory lead for consumer brands like HALLS, and Mead Johnson. Peer-reviewed publications in nutrition research. Bilingual in English and Chinese. Engagements: hourly, fixed-price, short reviews, or ongoing retainer. I work across US, Canada, and Asia time zones and can start quickly. Message me with your product and timeline — I'll tell you within a day whether I can help and what it would take.
Earnings and projects
Last 6 months ÷ 6
Across 47 contracts